COVID-19 therapy: corticosteroids including dexamethasone and hydrocortisone

Document first published:
Page updated:
Topic:
Publication type:

Guidance on the use of systemic corticosteroids in patients with severe and critical COVID-19 disease.

This letter also confirms that they should not be used in patients with non-severe COVID-19.

Link

COVID-19 therapy: corticosteroids including dexamethasone and hydrocortisone

COVID-19 therapy: corticosteroids including dexamethasone and hydrocortisone

NHS England is not responsible for content on external websites.

Summary

Letter from Dr Keith Ridge CBE, Chief Pharmaceutical Officer, and Professor Stephen Powis, NHS National Medical Director.

Published 13 November 2020.

Document

COVID-19 therapy: corticosteroids including dexamethasone and hydrocortisone

COVID-19 therapy: corticosteroids including dexamethasone and hydrocortisone

  • PDF
  • 81 KB
  • 2 pages

Summary

Letter from Dr Keith Ridge CBE, Chief Pharmaceutical Officer, and Professor Stephen Powis, NHS National Medical Director.

Published 13 November 2020.